Published in Malaria Weekly, May 18th, 2009
" Patients with prion disease were recruited via the UK national referral system and were offered a choice between quinacrine (300 mg daily), no quinacrine, or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Malaria Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.